Towards Optimal Treatment for High Risk Prostate Cancer
Recruiting
N/A
Interventional Study
High Risk Prostate Carcinoma
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Male
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 207 (estimated)
- Sponsor
- Haaglanden Medical Centre · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to combine several optimized treatments of high risk prostate cancer. The main question to answer is: is it safe to combine these optimized treatments.
* patients will be irradiated on the prostate and (elective) lymph nodes more concentrated but with fewer hospital visits (hypofractionation)
* the tumor will get a higher dose
* androgen deprivation therapy will…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men (aged ≥18 years of age) diagnosed within 6 months before inclusion with high risk prostate cancer:
* T3 based on digital rectal examination AND/OR
* Grade \>= 4 AND/OR
* PSA \>=20 ug/L
* Indication for elective lymph node irradiation (based on current clinical guide…
Contacts